BridgeMD
New treatment option for Hepatocellular Carcinoma
Official title Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
ClinicalTrials.gov ID: NCT03686709
What this study is testing
- What it's testing
- The objective of this study is to examine critical aspects of radiation exposure, dose delivery, and systemic yttrium-90 (Y90) exposure related to the infusion of Y90 microspheres for treatment of hepatocellular carcinoma (HCC) and other metastatic liver disease.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- All patients undergoing Y90 radioembolization therapy with SIR-Spheres or TheraSpheres are eligible to participate in this study
- Must be able to schedule and tolerate additional PET/CT imaging following therapy
- Must be able to tolerate additional blood draws before, during, and after the radioembolization therapy procedure.
You likely can't join if
- Patients that are not candidates for Y90 radioembolization therapy
- Patients that cannot tolerate additional imaging procedures following therapy
- Patients that cannot tolerate the additional blood draws required for this study
- Patients whose schedule does not allow them to remain at the hospital for the additional PET/CT imaging study
The study team makes the final eligibility decision.
Where it's taking place
- Knoxville, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Knoxville, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.